Commercial-stage biotech with integrated R&D, manufacturing, and sales across China and US
BioRay is a commercial-stage biopharmaceutical company operating four R&D and manufacturing centers across China (Taizhou, Hangzhou, Shanghai) and San Diego, with over 1,300 employees. The tech stack—LIMS, LabVantage, Oracle, SQL Server, UPLC/HPLC, JMP, Minitab, and SAP—reflects a regulated manufacturing operation focused on data integrity and analytical control. Active projects center on GMP compliance, technology transfer, process validation, and post-market surveillance; pain points cluster around lab efficiency, talent retention, and audit readiness, signaling operational scaling challenges typical of transition from development into commercial manufacturing and sales.
BioRay discovers, develops, manufactures, and commercializes medicines for immune-mediated diseases, with particular focus on autoimmune conditions and cancer. The company operates a four-center footprint spanning China and the US, supported by over 1,300 employees. Pipeline includes more than 20 preclinical candidates and over 10 ongoing clinical projects, with four marketed products in mainland China. Sales-focused hiring (16 open roles) and manufacturing headcount (12) reflect active commercial expansion. Full-spectrum capabilities span drug discovery through late-stage development, commercial-scale manufacturing, quality management, and established nationwide distribution.
LIMS, LabVantage, Oracle, SQL Server, Python, JavaScript, UPLC, HPLC, JMP, Minitab, AWS Database Migration Service, SAP. Heavy emphasis on laboratory information and analytical chemistry infrastructure.
Four centers: three in China (Taizhou, Hangzhou, Shanghai) and one in San Diego, US. Taizhou headquarters is in Zhejiang Province.
Over 1,300 employees worldwide across R&D, manufacturing, commercial, and operations.
Other companies in the same industry, closest in size